Physician profile
Stephen C Hill
NPI 1104489582
$1,203.16
in general payments reported to CMS, 2019-2025
16 companies · $959 in 2025
The $959 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $245 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699 · Travel and Lodging: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.81 |
| Travel and Lodging | $504.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $550.69 | 2024-2025 | Aquabeam System |
| Boston Scientific Corporation | $124.68 | 2024 | Ams 800 Artificial Urinary Sphincter |
| Urogen Pharma, INC. | $76.55 | 2025 | |
| Blue Earth Diagnostics | $61.37 | 2025 | Posluma |
| Teleflex LLC | $58.01 | 2025 | Barrigel |
| Endo USA, INC. | $51.77 | 2025 | Xiaflex, Aveed |
| Tolmar, INC. | $48.82 | 2025 | Jatenzo, Eligard |
| Medtronic, INC. | $30.29 | 2024 | Interstim |
| Sumitomo Pharma America, INC. | $30.28 | 2025 | Gemtesa |
| Abbvie INC. | $29.03 | 2025 | |
| Antares Pharma, INC. | $28.51 | 2024 | Xyosted |
| Progenics Pharmaceuticals, INC. | $28.43 | 2025 | |
| Ferring Pharmaceuticals INC. | $25.60 | 2024 | Adstiladrin |
| Calyxo, INC. | $22.61 | 2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $18.30 | 2024 | Prolaris |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $18.22 | 2025 | Bard Urinary Drainage Bag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.